ATE100711T1 - Verwendung von triazin- und pyrimidinderivaten zur herstellung von arzneimitteln zur ueberwindung der arzneimittelresistenz gegenueber antikrebs- und antimalariamittel. - Google Patents

Verwendung von triazin- und pyrimidinderivaten zur herstellung von arzneimitteln zur ueberwindung der arzneimittelresistenz gegenueber antikrebs- und antimalariamittel.

Info

Publication number
ATE100711T1
ATE100711T1 AT91402472T AT91402472T ATE100711T1 AT E100711 T1 ATE100711 T1 AT E100711T1 AT 91402472 T AT91402472 T AT 91402472T AT 91402472 T AT91402472 T AT 91402472T AT E100711 T1 ATE100711 T1 AT E100711T1
Authority
AT
Austria
Prior art keywords
triazine
pharmaceuticals
cancer
manufacture
drug resistance
Prior art date
Application number
AT91402472T
Other languages
English (en)
Inventor
Bernard Paramelle
Xavier Leverve
Gilbert Regnier
Alain Dhainaut
Ghanem Atassi
Alain Pierre
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE100711T1 publication Critical patent/ATE100711T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT91402472T 1990-09-27 1991-09-18 Verwendung von triazin- und pyrimidinderivaten zur herstellung von arzneimitteln zur ueberwindung der arzneimittelresistenz gegenueber antikrebs- und antimalariamittel. ATE100711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9011887A FR2667243B1 (fr) 1990-09-27 1990-09-27 Utilisation de s derives de la triazine et de la pyrimidine pour l'obtention de medicaments reversant la resistance aux agents anticancereux et antimalariques.
EP91402472A EP0478416B1 (de) 1990-09-27 1991-09-18 Verwendung von Triazin- und Pyrimidinderivaten zur Herstellung von Arzneimitteln zur Überwindung der Arzneimittelresistenz gegenüber Antikrebs- und Antimalariamittel

Publications (1)

Publication Number Publication Date
ATE100711T1 true ATE100711T1 (de) 1994-02-15

Family

ID=9400676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91402472T ATE100711T1 (de) 1990-09-27 1991-09-18 Verwendung von triazin- und pyrimidinderivaten zur herstellung von arzneimitteln zur ueberwindung der arzneimittelresistenz gegenueber antikrebs- und antimalariamittel.

Country Status (14)

Country Link
US (1) US5225405A (de)
EP (1) EP0478416B1 (de)
JP (1) JPH0761943B2 (de)
AT (1) ATE100711T1 (de)
AU (1) AU648584B2 (de)
CA (1) CA2052441A1 (de)
DE (1) DE69101097T2 (de)
DK (1) DK0478416T3 (de)
ES (1) ES2062724T3 (de)
FR (1) FR2667243B1 (de)
IE (1) IE65594B1 (de)
NZ (1) NZ239953A (de)
PT (1) PT99091B (de)
ZA (1) ZA917699B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821961A4 (de) * 1995-04-20 1999-03-31 Nippon Shinyaku Co Ltd Inhibitor der neovaskularisation
ES2145624T3 (es) 1996-08-13 2000-07-01 Kyowa Hakko Kogyo Kk Comprimidos a base de urea marcada con isotopos.
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
WO2018134265A1 (en) 2017-01-17 2018-07-26 Forrest Michael David Therapeutic inhibitors of the reverse mode of atp synthase
IL271845B2 (en) * 2017-07-13 2024-06-01 Michael David Forrest Therapeutic modulators of the reverse mode of atp synthase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256513A (de) * 1968-10-02 1971-12-08
FR2521560A1 (fr) * 1982-02-17 1983-08-19 Adir Nouveaux derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2524467A1 (fr) * 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2525597B1 (fr) * 1982-04-21 1985-06-07 Adir Polymethylene diamines n,n'-substituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2544315B1 (fr) * 1983-04-12 1985-07-05 Adir Polymethylene imines disubstituees, leurs procedes de preparation, et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
EP0478416B1 (de) 1994-01-26
ES2062724T3 (es) 1994-12-16
FR2667243A1 (fr) 1992-04-03
DE69101097T2 (de) 1994-08-04
FR2667243B1 (fr) 1994-11-04
PT99091B (pt) 1999-02-26
CA2052441A1 (fr) 1992-03-28
IE65594B1 (en) 1995-11-01
DK0478416T3 (da) 1994-05-02
ZA917699B (en) 1992-06-24
US5225405A (en) 1993-07-06
JPH0672878A (ja) 1994-03-15
NZ239953A (en) 1997-06-24
AU648584B2 (en) 1994-04-28
JPH0761943B2 (ja) 1995-07-05
IE913375A1 (en) 1992-04-08
EP0478416A1 (de) 1992-04-01
PT99091A (pt) 1992-08-31
DE69101097D1 (de) 1994-03-10
AU8475291A (en) 1992-04-02

Similar Documents

Publication Publication Date Title
DE69223914D1 (de) 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
DE60322359D1 (de) Imidazopyridinderivate als kinaseinhibitoren
DE68911742D1 (de) Substituierte flavonoide Verbindungen, ihre Salze, ihre Herstellung und die enthaltende Arnzeizusammensetzungen.
BR0215312A (pt) Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto
ATE122668T1 (de) Diarylsubstituierte heterocyclische verbindung, ihre herstellung und arzneimittel und kosmetika daraus.
ATE68180T1 (de) Morpholinoethylester von mycophenolsaeure und ihre derivate, ihre herstellung und verwendung in pharmazeutische zusammensetzungen.
ATE29255T1 (de) Succinimid-derivate und deren herstellung.
DE68917485D1 (de) Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
ES2056692T3 (es) Triacinas y pirimidinas trisustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
DE69222698D1 (de) 4-desoxy-4-epipodophyllotoxinderivate oder deren pharmazeutisch akzeptierbaren salze
ATE110365T1 (de) 2-alkyl-4-arylmethylaminochinoline, ihre verwendung und daraus hergestellte arzneimittel.
DE69101097D1 (de) Verwendung von Triazin- und Pyrimidinderivaten zur Herstellung von Arzneimitteln zur Überwindung der Arzneimittelresistenz gegenüber Antikrebs- und Antimalariamittel.
IT1224405B (it) Composti attivi sul sistema cardiovascolare
ATE138380T1 (de) Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
DE69422532D1 (de) 2-[4-(4-Azolylbutyl)-1-piperazinyl]-5-hydroxypyrimidin-Derivate, deren Herstellung und deren Verwendung als Heilmittel
SE8700555L (sv) Purinderivat, deras framstellning och lekemedel innehallande dessa
ATE3769T1 (de) 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
ATE62226T1 (de) Neue 3-pyridylmethylnaphthylderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE184875T1 (de) Imidazo(1,2-a>indeno(1,2-e>pyrazin-2-carbonsäur derivate, ihre herstellung und sie enthaltende arzneimittel
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
FR2470111B1 (fr) Derives de la decaprenylamine, leurs sels acides d'addition et composition pharmaceutique utilisant ces produits
ATE117682T1 (de) Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen.
ATE160937T1 (de) Die verwendung von 2-phenylmethylene-1-3'-(amino)-2-(hydroxy)-prop xy-imino-cyclohexane-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee